Crossmark

Authors’ Response to Silverman and Colleagues’ Comment on “Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence”

Crossref DOI link: https://doi.org/10.1007/s40264-018-0692-9

Published Online: 2018-06-28

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dasgupta, Nabarun https://orcid.org/0000-0002-4098-605X
Saucier, Roxanne

Wolfe, Daniel
Funding

Funding for this research was provided by:

Open Society Foundations
License Information

Text and Data Mining valid from 2018-06-28
More Information

Article History

First Online: 28 June 2018

Compliance with Ethical Standards

:

: No funding was received for the preparation of this letter.

: Daniel Wolfe is an employee of Open Society Foundations and Roxanne Saucier is a consultant to Open Society Foundations. Nabarun Dasgupta is a part-time employee of the RADARS System, which had no involvement in this letter. The RADARS System is supported by subscriptions from pharmaceutical manufacturers, and governmental and non-governmental agencies for data, research, and reporting services. The RADARS System is the property of the Denver Health and Hospital Authority, a political subdivision of the State of Colorado (USA). Employees are prohibited from financial relationships with any biopharmaceutical company.

Document is current

Any future updates will be listed below